Interactive Features

Sponsored

Test Your Knowledge

Quiz: Staging System for Endometrial Cancer

12/19/2019

True or false: The staging system developed by the International Federation of Obstetrics and Gynecology (FIGO) is the most frequently utilized staging system for endometrial cancer.

True or false: The staging...

12/19/2019

Oncology

Sponsored

Test Your Knowledge

Quiz: Risk Factors for Endometrial Cancer

12/19/2019

True or False: Many risk factors for endometrial cancer are related to ___.

True or False: Many risk factors...

12/19/2019

Oncology

Sponsored

Test Your Knowledge

Quiz: DNA Repair Pathways in Endometrial Cancer

12/17/2019

True or false: DNA repair pathways are often altered in endometrial cancer.

True or false: DNA repair...

12/17/2019

Oncology

Sponsored

Test Your Knowledge

Quiz: Endometrial Cancers Account for What Percentage of All Uterine Cancers?

12/11/2019

Endometrial cancers account for ___ of all uterine cancers.

Endometrial cancers account for...

12/11/2019

Oncology

Sponsored

Test Your Knowledge

Quiz: Deaths From Endometrial Cancer on the Rise

11/21/2019

In the past 10 years, death rates from endometrial cancers have increased by ___.

In the past 10 years, death...

11/21/2019

Oncology

Sponsored

Test Your Knowledge

Quiz: Systemic Therapy Options for Advanced or Recurrent Endometrial Cancer

11/20/2019

True or false: Options for systemic therapy in advanced or recurrent endometrial cancer include chemotherapy, immunotherapy/biologic therapy, and hormone therapy.

True or false: Options for...

11/20/2019

Oncology

Sponsored

Test Your Knowledge

Quiz: Increased Endometrial Cancer Rates in the Past Decade

11/07/2019

In the past decade, the rate of new cases of endometrial cancers have increased by what percentage?

In the past decade, the rate of...

11/07/2019

Oncology

Sponsored

Test Your Knowledge

Quiz: Treatment for Early-Stage Endometrial Cancer

10/20/2019

True or false: Treatment for early-stage endometrial cancer generally involves a combination of surgery, radiotherapy, and chemotherapy.

True or false: Treatment for...

10/20/2019

Oncology

Sponsored

Test Your Knowledge

Quiz: 5-year Relative Survival Rates for Localized, Regional, and Distant Endometrial Cancer

10/16/2019

What are the respective 5-year relative survival rates for localized, regional, and distant endometrial cancer?

What are the respective 5-year...

10/16/2019

Oncology

Sponsored

Test Your Knowledge

Quiz: How are Endometrial Cancers Traditionally Classified?

10/11/2019

True or False: Endometrial cancers are traditionally classified by tumor histology and grade.

True or False: Endometrial...

10/11/2019

Oncology

Recent News

News

Osimertinib Lacks Activity in Neoadjuvant Setting for Early-Stage Non-Small Cell Lung Cancer With EGFR Mutation

08/08/2024

Stephanie Holland ;

Results from a phase 2 study demonstrated that neoadjuvant osimertinib did not improve the major pathological response rate among patients with early-stage non-small cell lung cancer harboring an EGFR mutation.

Results from a phase 2 study...

08/08/2024

Oncology

FDA Approval

FDA Approves Denileukin Diftitox for Patients With R/R Cutaneous T-Cell Lymphoma

08/08/2024

Amber Denham ;

The US Food and Drug Administration approved novel immunotherapy denileukin diftitox-cxdl for the treatment of patients with relapsed/refractory cutaneous T-cell lymphoma after at least 1 prior systemic therapy.

The US Food and Drug...

08/08/2024

Oncology

News

Tailored Dose-Dense Chemotherapy Improved Survival Outcomes Among Patients With High-Risk Early Breast Cancer

08/07/2024

Stephanie Holland ;

According to results from the phase 3 PANTHER trial, tailored and dose-dense chemotherapy in the adjuvant setting improved survival outcomes compared to standard chemotherapy among patients with high-risk early breast cancer.

According to results from the...

08/07/2024

Oncology

News

Frontline Treatment Management for Patients With FL Reduces Risk of High-Grade Transformation to DLBCL

08/07/2024

Amber Denham ;

A recent study demonstrated that frontline treatment management reduced the risk of high-grade transformation to diffuse large B-cell lymphoma among patients with follicular lymphoma, but not among patients with marginal zone lymphoma.

A recent study demonstrated that...

08/07/2024

Oncology

News

Optimal Sotorasib Dose for Patients With KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer

08/07/2024

Stephanie Holland ;

Results from a phase 2 study found that 960 mg of sotorasib is preferable to 240 mg among patients with previously treated KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer.

Results from a phase 2 study...

08/07/2024

Oncology

FDA Approval

FDA Approves Vorasidenib for Patients With IDH1/IDH2-Mutated Grade 2 Astrocytoma or Oligodendroglioma

08/06/2024

Stephanie Holland ;

Based on results from the INDIGO trial, the FDA has approved vorasidenib for adult and pediatric patients 12 years and older with grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation following surgery.

Based on results from the INDIGO...

08/06/2024

Oncology

FDA Approval

FDA Approves Afamitresgene Autoleucel for Certain Unresectable or Metastatic Synovial Sarcoma

08/02/2024

Allison Casey ;

On August 2, 2024, the US Food and Drug Administration (FDA) granted accelerated approval to afamitresgene autoleucel for the treatment of adult patients with certain unresectable or metastatic synovial sarcomas who had received prior...

On August 2, 2024, the US Food...

08/02/2024

Oncology

FDA Approval

FDA Approves Dostarlimab Plus Chemotherapy for Patients With Primary Advanced or Recurrent Endometrial Cancer

08/01/2024

Allison Casey ;

The FDA approved dostarlimab plus carboplatin and paclitaxel, followed by single-agent dostarlimab for patients with primary advanced or recurrent endometrial cancer.

The FDA approved dostarlimab...

08/01/2024

Oncology

News

Iadademstat and Azacitidine Combination Therapy Demonstrates Manageable Safety, Promising Efficacy for Patients With Newly Diagnosed AML

08/01/2024

Amber Denham ;

The first-line combination of iadademstat and azacitidine demonstrates a manageable safety profile and promising results among patients with acute myeloid leukemia, according to phase 2 results from the ALICE trial.

The first-line combination of...

08/01/2024

Oncology

News

Effect of Food on Selumetinib Dosing for Adolescent Patients With Neurofibromatosis Type 1 With Plexiform Neurofibromas

08/01/2024

Allison Casey ;

In the phase 1 trial, the addition of a low-fat meal with doses of selumetinib did not significantly impact selumetinib exposure or gastrointestinal toxicities among adolescent patients with neurofibromatosis type 1 with plexiform...

In the phase 1 trial, the...

08/01/2024

Oncology